Télécharger le supplément (250 p.) - KCE

More documents

Recommendations

Info

134 Médecine à l'acte / médecine au forfait - ANNEXES KCE Reports 85 S Parameter Estimate Standard Error t Value Pr > |t| age*aidsoc 25-39 ans 2 0.000000 B . . . age*aidsoc 40-64 ans 1 -595.071286 B 1248.979717 -0.48 0.6338 age*aidsoc 40-64 ans 2 0.000000 B . . . age*aidsoc 5-24 ans 1 -595.593914 B 1269.483187 -0.47 0.6390 age*aidsoc 5-24 ans 2 0.000000 B . . . age*aidsoc 65-74 ans 1 -628.802280 B 1210.041878 -0.52 0.6033 age*aidsoc 65-74 ans 2 0.000000 B . . . age*aidsoc 75-84 ans 1 -574.277771 B 1260.122267 -0.46 0.6486 age*aidsoc 75-84 ans 2 0.000000 B . . . age*aidsoc 85-+ ans 1 0.000000 B . . . age*aidsoc 85-+ ans 2 0.000000 B . . . im*inv 1 1 123.944918 B 210.237895 0.59 0.5555 im*inv 1 2 0.000000 B . . . im*inv 2 1 0.000000 B . . . im*inv 2 2 0.000000 B . . . im*PP0020 1 1 90.803029 B 118.243311 0.77 0.4425 im*PP0020 1 2 0.000000 B . . . im*PP0020 2 1 0.000000 B . . . im*PP0020 2 2 0.000000 B . . . im*prep 1 1 -466.054932 B 723.670981 -0.64 0.5196 im*prep 1 2 0.000000 B . . . im*prep 2 1 0.000000 B . . . im*prep 2 2 0.000000 B . . . im*VPO 1 1 -19.239182 B 213.672035 -0.09 0.9283 im*VPO 1 2 0.000000 B . . . im*VPO 2 1 0.000000 B . . . im*VPO 2 2 0.000000 B . . . im*chom3 1 1 -112.200145 B 213.847900 -0.52 0.5998 im*chom3 1 2 0.000000 B . . . im*chom3 2 1 0.000000 B . . . im*chom3 2 2 0.000000 B . . . im*aidsoc 1 1 -150.411919 B 306.689257 -0.49 0.6238 im*aidsoc 1 2 0.000000 B . . . im*aidsoc 2 1 0.000000 B . . . im*aidsoc 2 2 0.000000 B . . . inv*PP0020 1 1 685.268981 B 184.997090 3.70 0.0002 inv*PP0020 1 2 0.000000 B . . . inv*PP0020 2 1 0.000000 B . . . inv*PP0020 2 2 0.000000 B . . . inv*chom3 1 1 -1046.545994 B 797.966481 -1.31 0.1897 inv*chom3 1 2 0.000000 B . . . inv*chom3 2 1 0.000000 B . . . inv*chom3 2 2 0.000000 B . . . inv*aidsoc 1 1 481.662852 B 620.966224 0.78 0.4380 inv*aidsoc 1 2 0.000000 B . . . inv*aidsoc 2 1 0.000000 B . . . inv*aidsoc 2 2 0.000000 B . . . PP0020*prep 1 1 241.635110 B 647.545847 0.37 0.7090 PP0020*prep 1 2 0.000000 B . . . PP0020*prep 2 1 0.000000 B . . . PP0020*prep 2 2 0.000000 B . . . PP0020*VPO 1 1 105.229090 B 198.873927 0.53 0.5967 PP0020*VPO 1 2 0.000000 B . . . PP0020*VPO 2 1 0.000000 B . . . PP0020*VPO 2 2 0.000000 B . . . PP0020*chom3 1 1 -8.097249 B 126.117586 -0.06 0.9488 PP0020*chom3 1 2 0.000000 B . . . PP0020*chom3 2 1 0.000000 B . . . PP0020*chom3 2 2 0.000000 B . . . PP0020*aidsoc 1 1 -117.711293 B 210.559733 -0.56 0.5761 PP0020*aidsoc 1 2 0.000000 B . . .
KCE Reports 85 S Médecine à l'acte : médecine au forfait - ANNEXES 135 Parameter Estimate Standard Error t Value Pr > |t| PP0020*aidsoc 2 1 0.000000 B . . . PP0020*aidsoc 2 2 0.000000 B . . . prep*VPO 1 1 -63.684784 B 990.914668 -0.06 0.9488 prep*VPO 1 2 0.000000 B . . . prep*VPO 2 1 0.000000 B . . . prep*VPO 2 2 0.000000 B . . . prep*aidsoc 1 1 280.409672 B 1160.797238 0.24 0.8091 prep*aidsoc 1 2 0.000000 B . . . prep*aidsoc 2 1 0.000000 B . . . prep*aidsoc 2 2 0.000000 B . . . VPO*chom3 1 1 -29.758134 B 714.412461 -0.04 0.9668 VPO*chom3 1 2 0.000000 B . . . VPO*chom3 2 1 0.000000 B . . . VPO*chom3 2 2 0.000000 B . . . VPO*aidsoc 1 1 -93.666204 B 510.574294 -0.18 0.8544 VPO*aidsoc 1 2 0.000000 B . . . VPO*aidsoc 2 1 0.000000 B . . . VPO*aidsoc 2 2 0.000000 B . . . chom3*aidsoc 1 1 23.176999 B 301.532965 0.08 0.9387 chom3*aidsoc 1 2 0.000000 B . . . chom3*aidsoc 2 1 0.000000 B . . . chom3*aidsoc 2 2 0.000000 B . . . The X'X matrix has been found to be singular, and a generalized inverse was used to solve the normal equations. Terms whose estimates are followed by the letter 'B' are not uniquely estimable. Essai 2 - en enlevant les intéractions non significatives Class Level Information Class Levels Values age 7 1-4 ans 25-39 ans 40-64 ans 5-24 ans 65-74 ans 75-84 ans 85-+ ans im 2 1 2 inv 2 1 2 PP0020 2 1 2 prep 2 1 2 VPO 2 1 2 chom3 2 1 2 aidsoc 2 1 2 Number of Observations Read 21778 Number of Observations Used 21778 Source DF Sum of Squares Mean Square F Value Pr > F Model 19 2718600538.4 143084238.87 18.00 F age 6 738831546.0 123138591.0 15.49
Page 1 and 2:
Comparaison du coût et de la quali
Page 3 and 4:
Comparaison du coût et de la quali
Page 5 and 6:
KCE Reports 85 S Médecine à l’a
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88: KCE Reports 85 S Médecine à l’a
Page 113 and 114: KCE Reports 85 S Médecine à l'act
Page 137: KCE Reports 85 S Médecine à l'act
Page 189 and 190:
KCE Reports 85 S Médecine à l'act
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
This page is left intentionally bla
Page 247 and 248:
KCE reports 1. Efficacité et renta
Page 249:
74. Oxygénothérapie Hyperbare: Ra
show all

Télécharger le supplément (250 p.) - KCE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?